MiMedx Group, Inc. (MDXG)
NASDAQ
Closed
Oct 23, 2026
Day's Range
3.8552 wk Range
3.03Profile - MDXG - MiMedx Group, Inc.
Profile
Mic Code
XNCM
Sector
Healthcare
Industry
Biotechnology
Employees
808
MiMedx Group, Inc. is a healthcare company focused on regenerative biologics and advanced wound care products. MiMedx Group, Inc. develops, manufactures, and markets placental tissue allografts and other biomaterial products used in wound care, surgical, burn, orthopedic, spine, sports medicine, ophthalmic, and dental applications. Its portfolio includes products derived from human placental and umbilical cord tissues, designed to support tissue repair and biologic healing in clinical settings. The company serves hospitals, physicians, and other healthcare providers through a range of wound management and surgical solutions. MiMedx Group, Inc. operates as a specialized player in the broader regenerative medicine market, with products that are used across multiple therapeutic areas where biologic tissue processing and advanced treatment options are important.
Profile Details
Type
Common Stock
Address
1775 West Oak Commons Court, NE
City
Marietta
State
GA
Zip
30062
Country
United States
Phone
770 651 9100
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
